Nomad Power Solutions (NMAD) Assets Average (2011 - 2026)
Nomad Power Solutions (NMAD) posted Assets Average of $19.7 million for Q2 2026, up 116.78% on a QoQ basis from $9.1 million in Q4 2025, and up 1357.1% year-over-year from $1.4 million in Q2 2025.
Analysis
Nomad Power Solutions (NMAD) Assets Average (2011 - 2026) Analysis & Trends
Nomad Power Solutions has reported Assets Average for 16 years, with the latest figure at $19.7 million in Q2 2026.
- On a quarterly basis, Assets Average rose 1357.1% year-over-year to $19.7 million in Q2 2026; TTM through Jun 2026 was $19.7 million, a 1357.1% increase from a year earlier, with the FY2025 full-year figure at $6.9 million, up 154.47% from the prior year.
- Assets Average was $19.7 million for Q2 2026 at Nomad Power Solutions, up from $9.1 million in the prior quarter.
- The five-year high for Assets Average was $19.7 million in Q2 2026, with the low at $1.3 million in Q1 2025.
- Average Assets Average over 5 years is $5.1 million, with a median of $4.2 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Assets Average tumbled 70.23% in 2024, then surged 1357.1% in 2026.
- Over 5 years, Assets Average stood at $6.2 million in 2022, then slipped by 22.92% to $4.8 million in 2023, then sank by 70.23% to $1.4 million in 2024, then surged by 539.38% to $9.1 million in 2025, then jumped by 116.78% to $19.7 million in 2026.
- The last three Assets Average figures came in at $19.7 million (Q2 2026), $9.1 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.51 Bn |
| 10 | Nomad Power Solutions | 49.59 Mn | 49.59 Mn | - | 19.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.69 Mn |
| Dec 31, 2025 | 9.08 Mn |
| Sep 30, 2025 | 3.31 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 3.13 Mn |
| Mar 31, 2024 | 3.95 Mn |
| Dec 31, 2023 | 4.77 Mn |
| Sep 30, 2023 | 4.16 Mn |
| Jun 30, 2023 | 3.71 Mn |
| Mar 31, 2023 | 4.95 Mn |
| Dec 31, 2022 | 6.19 Mn |
| Sep 30, 2022 | 7.42 Mn |
| Jun 30, 2022 | 6.07 Mn |
| Mar 31, 2022 | 4.61 Mn |
| Dec 31, 2021 | 5.71 Mn |
| Sep 30, 2021 | 6.79 Mn |
| Jun 30, 2021 | 7.57 Mn |